Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $35.69 USD
Change Today -0.64 / -1.76%
Volume 124.8K
INGN On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 4:30 PM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

inogen inc (INGN) Snapshot

Open
$36.38
Previous Close
$36.33
Day High
$36.39
Day Low
$35.19
52 Week High
04/27/15 - $40.80
52 Week Low
05/6/14 - $13.12
Market Cap
688.2M
Average Volume 10 Days
164.6K
EPS TTM
$0.29
Shares Outstanding
19.3M
EX-Date
--
P/E TM
122.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for INOGEN INC (INGN)

Related News

No related news articles were found.

inogen inc (INGN) Related Businessweek News

No Related Businessweek News Found

inogen inc (INGN) Details

Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. The company’s oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It offers Inogen One systems, which are portable devices that concentrate the air around the patients to provide a single source of supplemental oxygen; and Inogen At Home systems, as well as related accessories. The company also rents its products directly to patients. The company was founded in 2001 and is headquartered in Goleta, California.

411 Employees
Last Reported Date: 04/27/15
Founded in 2001

inogen inc (INGN) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $435.1K
Co-Founder, Chief Financial Officer, Principa...
Total Annual Compensation: $267.8K
Executive Vice President of Sales & Marketing
Total Annual Compensation: $256.1K
Compensation as of Fiscal Year 2014.

inogen inc (INGN) Key Developments

Inogen, Inc. Reports Unaudited Earnings Results for the Fourth Quarter and Year Ended December 31, 2014; Reaffirms Earnings Guidance for the Full Year of 2015

Inogen, Inc. reported unaudited earnings results for the fourth quarter and year ended December 31, 2014. For the quarter, total revenue was $29,118,000 against $19,762,000 a year ago. Income from operations was $1,432,000 against $553,000 a year ago. Income before provision for income taxes was $1,337,000 against $233,000 a year ago. Net income was $1,519,000 against $21,971,000 a year ago. Diluted net income per share attributable to common stockholders was $0.07 against $0.79 a year ago. EBITDA was $4,633,000 against $3,029,000 a year ago. Adjusted EBITDA was $4,961,000 against $3,203,000 a year ago. Adjusted net income was $1,261,000 against $164,000 a year ago. For the year, total revenue was $112,537,000 against $75,443,000 a year ago. Income from operations was $10,511,000 against $4,464,000 a year ago. Income before provision for income taxes was $10,052,000 against $3,848,000 a year ago. Net income was $6,826,000 against $25,435,000 a year ago. Diluted net income per share attributable to common stockholders was $0.30 against $0.68 a year ago. EBITDA was $22,539,000 against $12,942,000 a year ago. Adjusted EBITDA was $23,954,000 against $13,434,000 a year ago. Adjusted net income was $6,568,000 against $3,628,000 a year ago. The company increased its 2015 revenue guidance to a range of $133 million to $137 million, which represents year over year growth ranging from 18.2% to 21.7%. This compares to the previous revenue expectation of $130 million to $135 million which was provided on December 15, 2014. The company confirmed its 2015 Adjusted EBITDA to a range of $27 million to $30 million, representing an approximate increase of 12.7% to 25.2% over 2014. The company confirmed its 2015 net income to be in the range of $8 million to $9.5 million, representing an approximate increase of 17.2% to 39.2% over 2014. The company expects an effective tax rate of approximately 35%.

Inogen, Inc. to Report Q4, 2014 Results on Apr 27, 2015

Inogen, Inc. announced that they will report Q4, 2014 results at 5:30 AM, Pacific Standard Time on Apr 27, 2015

Brower Piven Commences Class Action Lawsuit Against Inogen

Brower Piven announced that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of purchasers of Inogen, Inc. common stock during the period between November 12, 2014 and March 11, 2015, inclusive. Investors who wish to become proactively involved in the litigation have until May 12, 2015 to seek appointment as lead plaintiff. The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that its Form 10-Q for the quarter ended September 30, 2014 contained materially false and misleading financial information. According to the complaint, following the company’s March 11, 2015 announcement that the company’s Audit Committee, with the assistance of independent advisors, commenced an investigation in connection with the company’s accounting policies and was postponing its scheduled fourth quarter 2014 and fiscal 2014 earnings release, the value of Inogen shares declined significantly.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INGN:US $35.69 USD -0.64

INGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Invacare Corp $20.31 USD -0.42
View Industry Companies
 

Industry Analysis

INGN

Industry Average

Valuation INGN Industry Range
Price/Earnings 100.0x
Price/Sales 5.9x
Price/Book 5.7x
Price/Cash Flow 99.3x
TEV/Sales 5.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INOGEN INC, please visit www.inogen.net. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.